Filing Details

Accession Number:
0001161697-22-000468
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-16 17:00:37
Reporting Period:
2022-09-14
Accepted Time:
2022-09-16 17:00:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1279473 Gary Ingenito 355 Alhambra Circle, Suite 801
Coral Gables FL 33134
Chief Medical & Reg. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-09-14 55,000 $4.01 77,053 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2022-09-14 55,000 $15.65 22,053 No 4 S Direct
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-09-14 88,000 $4.64 110,053 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2022-09-14 88,000 $15.69 22,053 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2022-09-14 55,000 $0.00 55,000 $4.01
Common Stock Options to purchase common stock Disposition 2022-09-14 88,000 $0.00 88,000 $4.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,016,667 2025-01-02 No 4 M Direct
928,667 2026-12-02 No 4 M Direct
Footnotes
  1. Dr. Ingenito sold the shares on the open market for personal reasons and not as a result of any disagreement with the Registrant. Dr. Ingenito remains an officer of the Company.
  2. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.56 to $15.80 per share.
  3. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.62 to $15.79 per share.
  4. Options vested in three annual tranches beginning on January 2, 2018.
  5. Options vested in two annual tranches beginning on December 2, 2020.